
How HBOT is meant to help grafts: oxygen, new vessels and survival
The theory behind HBOT after a hair transplant is about the first few days, while the grafts still have no blood vessels of their own.
The theory behind HBOT after a hair transplant is about the first few days, while the grafts still have no blood vessels of their own. Oxygen dissolved in plasma reaches places the red blood cells cannot, and pressure treatment affects both the formation of new blood vessels and inflammation. The mechanism is logical. That it delivers a clinical benefit is not proven.
What problem is HBOT supposed to solve after a hair transplant?

When a follicular unit is moved, it loses its blood supply. In the days before new blood vessels connect, it lives on plasmatic imbibition: oxygen and nutrients seep in from the surrounding tissue fluid. This period of too little oxygen is the most vulnerable point for the grafts, and it is where HBOT aims to provide extra oxygen.
The moment a follicular unit is taken from the donor area, its connection to the blood supply is cut. Placed in a small opening in the recipient area, it has no circulation of its own for several days. During that time it survives on plasmatic imbibition, meaning oxygen and nutrients seep in from the surrounding tissue fluid, until new blood vessels have grown and connected.
This ischaemic phase is the known weak point. Parsley and Perez-Meza have summarised what determines whether follicular grafts grow, and name the time the graft spends outside the body, handling damage, drying out and conditions at the recipient site as what decides how many grafts make it. If a graft gets better access to oxygen while it depends on diffusion, you are in theory tackling a real problem.
So the idea is not plucked out of thin air. It targets the right time window and the right physiological variable.
Why does pressure deliver more oxygen to the tissue?
In ordinary air at sea level, almost all oxygen is carried by haemoglobin, which is already about 97 % saturated. More oxygen in the air you breathe therefore does little. What dissolves in plasma, by contrast, follows Henry's law and rises in step with the partial pressure. At 2.0 to 2.4 ATA and 100 % oxygen the amount becomes many times larger, and the plasma can carry oxygen to places the red blood cells cannot yet reach.
When you breathe ordinary air at sea level, haemoglobin handles almost all oxygen transport, and it is already about 97 % saturated. A higher oxygen concentration in what you breathe barely helps, because there are almost no free binding sites.
Oxygen dissolved in plasma is different. Here Henry's law applies, which says the amount of gas that dissolves rises in proportion to the partial pressure. When you breathe pure oxygen, 100 %, at 2.0 to 2.4 ATA, the partial pressure becomes many times higher, and the dissolved amount rises accordingly.
What makes this clinically interesting is that the dissolved oxygen travels with the plasma and not with the red blood cells. Plasma gets to places the blood cells cannot reach right now: past swollen tissue, across a gap the oxygen has to diffuse over, and into an area where the capillaries have not yet formed. That is the concrete rationale for giving HBOT to a graft without its own circulation.
Does hyperbaric oxygen do more than deliver oxygen?
Yes. During pressure treatment, reactive oxygen and nitrogen species are formed, and they act as signalling molecules that influence growth factors, inflammation and how blood vessels behave. This stimulates angiogenesis, the formation of new blood vessels into tissue that is low in oxygen. Dong and Jin also point out that the treatment dampens local inflammatory factors, and that dermal papilla cells divided more in the laboratory.
Thom is worth reading carefully on this point. The usual explanation, that "the tissue gets more oxygen", simplifies what the research actually describes. Thom places the most important effects in reactive oxygen and nitrogen species formed inside the cells. These act as messengers in signalling pathways that control growth factors, the inflammatory response and how blood vessels behave.
Hyperbaric oxygen should therefore be seen more as a signal than as a delivery system. That explains findings that delivery alone cannot, for example that the effect lasts after a session has ended, and that repeating the treatment matters.
New blood vessels
The idea is that pressure treatment makes new blood vessels grow into an oxygen-poor wound area, so a graft depends on diffusion for a shorter time. The same mechanism underlies the established use of HBOT for difficult wounds and for skin grafts and flaps with poor healing. The evidence there, as Thom describes, comes mostly from animal studies and a few clinical studies.
Inflammation
Dong and Jin commented on the Fan study in a letter in the Journal of Cosmetic Dermatology. In it they suggested that dampened inflammation may account for part of any benefit. They cited research in which hyperbaric oxygen reduced local inflammatory factors. They also presented their own laboratory experiments with dermal papilla cells from human hair, in which the cells divided more and expressed more PCNA after pressure treatment than the control cells did.
Why doesn't a good mechanism guarantee a better result?
The Fan study shows that the mechanism can produce a measurable effect without changing the final result. Early shedding fell from 69.1 % to 27.6 %, and fewer patients had itching and folliculitis. At nine months, 96.9 % of grafts had survived in the HBOT arm versus 93.8 % among the controls, a gap without statistical significance. Perhaps the study was too small to capture a real difference. Perhaps the hair would have grown back anyway.
All of this gives good reasons to research HBOT. It is not proof that it works. That distinction easily gets lost when clinics market themselves, and it is how patients are most often misled about add-on treatments.
The Fan study is useful to look at precisely because the mechanism produces a measurable effect here that does not show up in the final result. Early shedding dropped sharply, from 69.1 % in the control group to 27.6 % with HBOT. That fits with the grafts getting better support through the ischaemic phase. Folliculitis and itching also became less common, which fits with less inflammation. Even so, survival at nine months ended up at 96.9 % with treatment and 93.8 % without, and the study could not show that the gap was statistically significant.
There are two interpretations. The first is that 34 patients were simply too few to detect a real difference of three percentage points, and that is entirely plausible. According to the second, the hair that fell out would have come back anyway. It is normal for transplanted hairs to fall out after surgery, and the follicle usually survives. Less visible shedding may then have made the first month easier for patients without the number of follicles ending up any higher.
The data we have support both interpretations. No published study has yet managed to tell them apart.
What would it take for the mechanism to be clinically convincing?
A study with enough participants to detect small differences in how many grafts survive, that follows patients for twelve months rather than nine, that counts hairs in a defined field of the recipient area, and that randomises so many people that the difference isn't drowned out by random variation. None of the four published studies meets these requirements.
Sources
- Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plastic and Reconstructive Surgery, 2011;127 Suppl 1:131S-141S. pubmed.ncbi.nlm.nih.gov/21200283
- Parsley WM, Perez-Meza D. Review of factors affecting the growth and survival of follicular graft. Journal of Cutaneous and Aesthetic Surgery, 2010;3(2). jcasonline.com
- Fan Z, Gan Y, Qu Q, Wang J, Lunan Y, Liu B, Chen R, Hu Z, Miao Y. The effect of hyperbaric oxygen therapy combined with hair transplantation surgery for the treatment of alopecia. Journal of Cosmetic Dermatology, 2021;20(3):917-921. pubmed.ncbi.nlm.nih.gov/32770782
- Dong X, Jin X. The effect of hyperbaric oxygen therapy combined with hair transplantation surgery for the treatment of alopecia [letter to the editor]. Journal of Cosmetic Dermatology, 2021. doi.org/10.1111/jocd.14131
- Bernstein RM, Rassman WR. Graft Anchoring in Hair Transplantation. Dermatologic Surgery, 2006;32(2):198-204. pubmed.ncbi.nlm.nih.gov/16442039
This article summarises published research and common clinical practice as general information. It is not medical advice and does not replace the instructions from the team operating on you. If they tell you something different from what you read here, follow their advice.
Wondering what's possible for your hair?
Send three sharp photos of your hair, from the front, the top and the back. You'll get an honest answer on what can be done, roughly how many grafts it would take and what it costs.
- Free and with no obligation
- Photos are assessed by the clinic's medical team
- Replies usually within an hour in the daytime
A study tells you something about groups. Only a doctor who has seen your photos can say what applies to your hair. The medical team at the clinic at the top of our ranking offers a free assessment.
Goes to the clinic at the top of our ranking.

